Fred Hutchinson Cancer Center clinical trial pipeline

18 trials changed in the last 30 days: 1 stopped, 11 with notable changes, 6 with minor changes only.

1. Stopped

   Novel Mobile Health Intervention for Improving Tobacco Cessation…Novel Mobile Health Intervention for Improving Tobacco Cessation Among Young Adults

   Trial terminated

   Also in this update: Final enrollment: 6 participants — 4% of the 140 planned; Primary completion date changed from estimate of Apr 1, 2028 to Jun 11, 2026

   Fred Hutchinson Cancer Center·Not applicable· NCT07571018· Registry history of NCT07571018 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

2. Notable

   Use of One Or Two Probes for Thermal Ablation Among Screen…Use of One Or Two Probes for Thermal Ablation Among Screen Positive Women Living With HIV in C1001P-CS2 Kenya

   Recruitment opened

   Also in this update: Primary endpoint(s) modified; Start date changed from estimate of Oct 15, 2026 to Oct 12, 2026; and 2 more changes in the last 30 days

   Fred Hutchinson Cancer Center·Not applicable· NCT07468695· Registry history of NCT07468695 on ClinicalTrials.gov (opens the registry)

   Oct 20, 2026

3. Notable

   One vs Two Probes for Thermal Ablation Among Cervical Cancer…One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa

   Recruitment opened

   Also in this update: Primary endpoint(s) modified; and 2 more changes in the last 30 days

   Fred Hutchinson Cancer Center·Not applicable· NCT07645378· Registry history of NCT07645378 on ClinicalTrials.gov (opens the registry)

   Oct 20, 2026

4. Notable

   Graft Versus Host Disease-Reduction Strategies for Donor Blood…Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant · Acute Leukemia or Myelodysplastic Syndrome (MDS)

   Primary completion pushed from Dec 31, 2027 to Dec 31, 2028

   Also in this update: Study completion pushed from Dec 31, 2029 to Dec 31, 2030

   Fred Hutchinson Cancer Center·Phase 2· NCT03970096· Registry history of NCT03970096 on ClinicalTrials.gov (opens the registry)

   Oct 20, 2026

5. Notable

   Estrogen to Improve Quality of Life · Newly Diagnosed or Recurrent…Estrogen to Improve Quality of Life · Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial

   Recruitment opened

   Fred Hutchinson Cancer Center·Phase 2· NCT07466498· Registry history of NCT07466498 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

6. Notable

   One vs Two Probes for Thermal Ablation Among Cervical Cancer…One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe

   Recruitment opened

   And 2 more changes in the last 30 days

   Fred Hutchinson Cancer Center·Not applicable· NCT07645352· Registry history of NCT07645352 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

7. Notable

   One vs Two Probes for TA Among Cervical Cancer Screen Positive…One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda

   Recruitment opened

   And 3 more changes in the last 30 days

   Fred Hutchinson Cancer Center·Not applicable· NCT07390916· Registry history of NCT07390916 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

8. Notable

   Educational Intervention (Lung Toolkit) for Improving Knowledge…Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial

   Recruitment opened

   Fred Hutchinson Cancer Center·Not applicable· NCT07615764· Registry history of NCT07615764 on ClinicalTrials.gov (opens the registry)

   Oct 16, 2026

9. Notable

   Unrestricted Payment Program for Early-stage Cancer Patients: the…Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial

   Start date pushed from Oct 1, 2026 to Nov 15, 2026

   Fred Hutchinson Cancer Center·Not applicable· NCT06771739· Registry history of NCT06771739 on ClinicalTrials.gov (opens the registry)

   Oct 20, 2026

10. Notable

    Acalabrutinib · Chronic Graft Versus Host Disease

    Results posted: Oct 14, 2026

    Fred Hutchinson Cancer Center·Phase 2· NCT04198922· Registry history of NCT04198922 on ClinicalTrials.gov (opens the registry)

    Oct 14, 2026

11. Notable

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host…Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young · Blood Cancers Undergoing Donor Stem Cell Transplant

    Primary and study completion moved earlier from Dec 31, 2028 to Aug 31, 2027

    Fred Hutchinson Cancer Center·Phase 2· NCT03779854· Registry history of NCT03779854 on ClinicalTrials.gov (opens the registry)

    Sep 25, 2026

12. Notable

    Design and Testing of a Web-Based Tool for the Improvement of…Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning · Advanced Cancer

    Results posted: Oct 2, 2026

    Fred Hutchinson Cancer Center·Not applicable· NCT05564468· Registry history of NCT05564468 on ClinicalTrials.gov (opens the registry)

    Oct 2, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.